Bipolar Disorder Treatment Market Size Trajectory Heading Towards USD 9.2 Billion by 2034, Growth at CAGR 5.4% | Report by Transparency Market Research, Inc.
Growing Acceptance of Combination Therapies is gaining acceptance, as the approach is often more effective than single agent treatments and offers better symptom control, driving market growth.
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 12, 2024 (GLOBE NEWSWIRE) — The bipolar disorder treatment market (双極性障害治療市場) was projected to attain US$ 5.1 billion in 2023. It is likely to garner a 5.4% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 9.2 billion.
Technological advancements in healthcare, such as telemedicine, digital health platforms, and wearable devices, are facilitating remote monitoring and management of bipolar disorder patients. The technologies enhance patient engagement, improve treatment adherence, and enable better disease management, thereby driving market growth.
Greater awareness about mental health issues, including bipolar disorder, is reducing the stigma associated with seeking treatment, which has led to more individuals seeking help for the symptoms, thereby expanding the market for bipolar disorder treatments.
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20855
Psychotherapy, including cognitive behavioral therapy, dialectical behavior therapy, and interpersonal therapy, is increasingly being recognized as an integral part of bipolar disorder treatment. The growing acceptance and adoption of psychotherapy as an adjunct to medication therapy offer new opportunities for mental health professionals and therapy providers.
The trend towards personalized medicine is gaining traction in the field of mental health. Advances in genetics, biomarkers, and neuroimaging techniques are enabling the development of personalized treatment regimens tailored to the specific needs of individual patients. The trend is expected to lead to more effective and targeted therapies for bipolar disorder, driving the market growth.
Key Findings of the Market Report
- Focus on early intervention and prevention can help prevent disease progression, reduce the severity of symptoms, and improve long term outcomes.
- Expanding Patient Assistance Programs play a vital role in improving access to bipolar disorder treatments, particularly for underserved populations.
- Growing research into novel therapeutic targets is uncovering novel therapeutic targets and treatment modalities.
- The identification of new drug targets and therapeutic approaches presents opportunities for drug discovery and development in the bipolar disorder treatment market.
Market Trends for Bipolar Disorder Treatment
- Rising demand for digital therapeutics offer convenient, scalable, and cost effective solutions for symptom management, mood tracking, psychoeducation, and behavioral interventions.
- Increasing focus on long-acting injectable medications is gaining popularity for the maintenance treatment of bipolar disorder.
- The formulations offer advantages such as improved adherence, reduced relapse rates, and convenience for patients who have difficulty adhering to oral medications, presenting opportunities for pharmaceutical companies to expand the product portfolios.
- Integration of digital biomarkers is enabling continuous monitoring of mood, activity levels, sleep patterns, and social interactions in individuals with bipolar disorder.
- The digital biomarkers provide valuable insights into disease progression, treatment response, and early warning signs of relapse, facilitating personalized and proactive management strategies.
Global Market for Bipolar Disorder Treatment: Regional Outlook
- Telepsychiatry services, which involve the delivery of mental health care services remotely via telecommunication technologies, are experiencing rapid expansion, particularly in rural and underserved areas.
- The increasing acceptance of telepsychiatry by patients, clinicians, and payers is widening access to bipolar disorder treatment, improving convenience, and reducing healthcare disparities.
- Emergence of novel drug delivery systems are opening up new possibilities for the delivery of bipolar disorder medications. The innovative delivery systems offer advantages such as improved bioavailability, sustained release, and enhanced patient compliance, driving interest from pharmaceutical companies and investors.
- Mindfulness based interventions, such as mindfulness meditation, yoga, and mindfulness based cognitive therapy, are gaining recognition as adjunctive treatments for bipolar disorder.
- There is growing recognition of the need to address treatment gaps and disparities in special populations affected by bipolar disorder, including children and adolescents, pregnant women, and older adults.
- The practices promote emotional regulation, stress reduction, and enhanced self-awareness, complementing pharmacological and psychotherapeutic approaches and offering holistic treatment options.
Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20855
Bipolar Disorder Treatment Market: Key Players
The bipolar disorder treatment market is characterized by a multidimensional approach, encompassing pharmaceuticals, medical devices, psychotherapy and research initiatives.
Market players compete based on product efficacy, safety, innovation, and market access, while striving to address complex individual requirements associated with bipolar disorders. The following companies are well known participants in the bipolar disorder treatment market:
- Otsuka Pharmaceutical Co. Ltd.
- AstraZeneca plc
- GSK plc
- Pfizer Inc.
- Eli Lilly and Company
- Johnson & Johnson
- AbbVie Inc.
- Novartis AG
- Allergan plc
- Lundbeck A/S
Key Developments
- In 2022, the FDA greenlit Intra-Cellular Therapies Inc.’s 10.5 mg and 21 mg lumateperone doses for addressing schizophrenia and bipolar depression.
- In the same year, BioXcel Therapeutics, Inc. revealed that the FDA granted approval for IGALMI (dexmedetomidine) sublingual film, designed for the immediate relief of agitation linked to schizophrenia or bipolar I or II disorder in adults.
Top of Form
Bipolar Disorder Treatment Market Segmentation
Type of Treatment
- Pharmacotherapy
- Psychotherapy
- Electroconvulsive Therapy (ECT)
- Transcranial Magnetic Stimulation (TMS)
- Others (Hospitalization, etc.)
Drug Class
- Mood Stabilizers
- Antipsychotics
- Anti-depressants
- Antianxiety Drugs
- Others (Anticonvulsants, etc.)
Type of Bipolar Disorder
- Bipolar I Disorder
- Bipolar II Disorder
- Cyclothymic Disorder
- Others (Specified and Unspecified Bipolar and Related Disorders, etc.)
End User
- Hospitals
- Specialty Clinics
- Mental Health Centers
- Ambulatory Surgical Centers
Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=20855<ype=S
More Trending Reports by Transparency Market Research –
- Autism Spectrum Disorder Treatment Market – The global autism spectrum disorder treatment market (自閉症スペクトラム障害治療市場) is projected to advance at a CAGR of 5.2% from 2024 to 2034.
- Thyroid Gland Disorders Treatment Market – The global thyroid gland disorders treatment market (甲状腺疾患治療市場) is projected to expand at a CAGR of 4.7% during the forecast period from 2023 to 2031.
- Bromelain Market – The global bromelain market (ブロメライン市場) is projected to grow at a CAGR of 7.4% from 2024 to 2034 and reach more than US$ 755.0 Mn by the end of 2034.
- Live Biotherapeutics Market – The global live biotherapeutics market (生きたバイオ医薬品市場) is projected to advance at a CAGR of 14% from 2024 to 2034 and reach more than US$ 422.9 Mn by the end of 2034.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
